High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2024 Aug 7

PMID 39110418

Authors

Shuai Xu

Fangmin Zhong

Junyao Jiang

Fangyi Yao

Meiyong Li

Mengxin Tang

Ying Cheng

Yulin Yang

Wen Wen

Xueru Zhang

Bo Huang

Xiaozhong Wang

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) remains a global health concern with persistently high incidence and mortality rates. However, the specific pathogenesis of CRC remains poorly understood. This study aims to investigate the role and pathogenesis of serine and arginine rich splicing factor 10 (SRSF10) in colorectal cancer.

Methods: Bioinformatics analysis was employed to predict SRSF10 gene expression in CRC patients. Functional experiments involving SRSF10 knockdown and overexpression were conducted using CCK8, transwell, scratch assay, and flow cytometry. Additionally, the PRIdictor website was utilized to predict the SRSF10 interaction site with RFC5. The identification of different transcripts of SRSF10-acting RFC5 pre-mRNA was achieved through agarose gel electrophoresis.

Result: The knockdown of SRSF10 inhibited the proliferation and migration ability of CRC cells, while promoting apoptosis and altering the DNA replication of CRC cells. Conversely, when SRSF10 was highly expressed, it enhanced the proliferation and migration ability of CRC cells and caused changes in the cell cycle of colorectal cancer cells. This study revealed a change in the replicating factor C subunit 5 (RFC5) gene in colorectal cancer cells following SRSF10 knockdown. Furthermore, it was confirmed that SRSF10 increased RFC5 exon2-AS1(S) transcription variants, thereby promoting the development of colorectal cancer through AS1 exclusion to exon 2 of RFC5.

Conclusion: In summary, this study demonstrates that SRSF10 promotes the progression of colorectal cancer by generating an aberrantly spliced exclusion isoform of AS1 within RFC5 exon 2. These findings suggest that SRSF10 could serve as a crucial target for the clinical diagnosis and treatment of CRC.

References

Weitz J, Koch M, Debus J, Hohler T, Galle P, Buchler M . Colorectal cancer. Lancet. 2005; 365(9454):153-65. DOI: 10.1016/S0140-6736(05)17706-X. View

Noskov V, Araki H, Sugino A . The RFC2 gene, encoding the third-largest subunit of the replication factor C complex, is required for an S-phase checkpoint in Saccharomyces cerevisiae. Mol Cell Biol. 1998; 18(8):4914-23. PMC: 109075. DOI: 10.1128/MCB.18.8.4914. View

Wrobel P, Ahmed S . Current status of immunotherapy in metastatic colorectal cancer. Int J Colorectal Dis. 2018; 34(1):13-25. DOI: 10.1007/s00384-018-3202-8. View

Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X . Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci. 2021; 17(14):3837-3849. PMC: 8495390. DOI: 10.7150/ijbs.64077. View

Loo S, Ab Hamid S, Musa M, Wong K . DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma. Pathol Res Pract. 2017; 214(1):134-143. DOI: 10.1016/j.prp.2017.10.005. View

Wright C, Smith C, Jiggins C . Alternative splicing as a source of phenotypic diversity. Nat Rev Genet. 2022; 23(11):697-710. DOI: 10.1038/s41576-022-00514-4. View

Liu D, Zhang X, Xi B, Wan D, Li L, Zhou J . Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer. Int J Oncol. 2014; 45(3):1232-40. DOI: 10.3892/ijo.2014.2510. View

Amirkhah R, Naderi-Meshkin H, Shah J, Dunne P, Schmitz U . The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer. Cells. 2019; 8(8). PMC: 6721676. DOI: 10.3390/cells8080929. View

Rahman M, Nasrin F, Bhattacharjee S, Nandi S . Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine. Cancers (Basel). 2020; 12(6). PMC: 7352608. DOI: 10.3390/cancers12061381. View

10.

Cho S, Hoang A, Sinha R, Zhong X, Fu X, Krainer A . Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc Natl Acad Sci U S A. 2011; 108(20):8233-8. PMC: 3100968. DOI: 10.1073/pnas.1017700108. View

11.

Zhao X, Sun Y, Sun X, Li J, Shi X, Liang Z . Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting . DNA Cell Biol. 2021; 40(7):895-905. DOI: 10.1089/dna.2020.6287. View

12.

Barfeld S, East P, Zuber V, Mills I . Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes. BMC Med Genomics. 2015; 7:513. PMC: 4351903. DOI: 10.1186/s12920-014-0074-9. View

13.

Zheng X, Peng Q, Wang L, Zhang X, Huang L, Wang J . Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer. Int J Biol Sci. 2020; 16(13):2442-2453. PMC: 7378643. DOI: 10.7150/ijbs.46751. View

14.

Liu S, Chen W, Wang J . Distinguishing between cancer cell differentiation and resistance induced by all-trans retinoic acid using transcriptional profiles and functional pathway analysis. Sci Rep. 2014; 4:5577. PMC: 4894425. DOI: 10.1038/srep05577. View

15.

Patel S, Karlitz J, Yen T, Lieu C, Boland C . The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022; 7(3):262-274. DOI: 10.1016/S2468-1253(21)00426-X. View

16.

Li W, Wu D, Zhou Y, Zhang C, Liao X . Prognostic biomarker replication factor C subunit 5 and its correlation with immune infiltrates in acute myeloid leukemia. Hematology. 2022; 27(1):555-564. DOI: 10.1080/16078454.2022.2072064. View

17.

Wang T, Chen X, Jing F, Li Z, Tan H, Luo Y . Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values. Pathol Res Pract. 2021; 228:153654. DOI: 10.1016/j.prp.2021.153654. View

18.

Shkreta L, Delannoy A, Salvetti A, Chabot B . SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication. RNA. 2021; 27(11):1302-1317. PMC: 8522700. DOI: 10.1261/rna.078879.121. View

19.

Sahebi M, Hanafi M, van Wijnen A, Azizi P, Abiri R, Ashkani S . Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins. Gene. 2016; 587(2):107-19. DOI: 10.1016/j.gene.2016.04.057. View

20.

Yao H, Zhou X, Zhou A, Chen J, Chen G, Shi X . RFC5, regulated by circ_0038985/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer. Mol Carcinog. 2023; 62(6):771-785. DOI: 10.1002/mc.23523. View